These findings all support that autophagy is the mechanism of cell survival which contribute to the resistance of NSCLC to EGFR-TKI, and autophagy inhibition can enhance the sensitivity of tumor cells to drugs. Here, EGFR is linked to non-small cell lung carcinoma.